(NASDAQ: ASMB) Assembly Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.57%.
Assembly Biosciences's earnings in 2025 is -$40,804,000.On average, 2 Wall Street analysts forecast ASMB's earnings for 2025 to be -$48,593,806, with the lowest ASMB earnings forecast at -$51,040,977, and the highest ASMB earnings forecast at -$46,146,636. On average, 2 Wall Street analysts forecast ASMB's earnings for 2026 to be -$65,533,309, with the lowest ASMB earnings forecast at -$68,965,703, and the highest ASMB earnings forecast at -$62,100,914.
In 2027, ASMB is forecast to generate -$93,373,841 in earnings, with the lowest earnings forecast at -$93,373,841 and the highest earnings forecast at -$93,373,841.